- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
GLJ
GER
Week ended 31 Jul 2026
Weekly Investor Report
Grenke AG · Financial Services · Credit Services
Latest close
11.76 EUR
0.9%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -9.4% below the Trend Line and sits at 3.6% of its 52-week range. The latest completed week returned 0.9%, after a -2.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 57/100.
Setup score
25
out of 100
Latest Close
11.76 EUR
31 Jul 2026
1W Return
0.9%
latest completed week
4W Return
-2.2%
short-term follow-through
12W Return
-3.8%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.9%
Latest completed week; four-week move -2.2%.
Indicator stack
14/20
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
57/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -9.4% below the Trend Line and sits at 3.6% of its 52-week range. The latest completed week returned 0.9%, after a -2.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0612-week average 0.04
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.2% over four weeks, -3.8% over 12 weeks, and -29.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.40Latest activity-pressure read.
Pressure change-284.8%Four-week change in activity pressure.
Leadership-20.47Latest relative-leadership reading.
RS change6.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 87%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength17/100Blend of value, momentum, and quality. Underlying universe rank 84; rank 1 is best.
Value62/100Relative valuation strength. Underlying universe rank 39; rank 1 is best.
Quality7/100Profitability and accounting quality. Underlying universe rank 94; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth71/100Revenue and earnings growth. Underlying universe rank 30; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework15/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 7.1x Price divided by trailing earnings.
- Price / sales
- 0.5x Market value relative to trailing revenue.
- EV / EBITDA
- 32.7x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -0.8% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 46.4% Gross profit retained from each unit of revenue.
- Operating margin
- 17.2% Operating profit retained from revenue.
- Free-cash-flow margin
- -3.9% Free cash flow generated from revenue.
- Return on invested capital
- 2.3% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 19.4% Latest one-year revenue growth.
- EPS growth
- -8.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -162.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 3.6% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 3.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 28.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 3 relevant articles.
1 positive · 2 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-38.7%Distance below the 52-week high.
13-week volatility3.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher13 of 2612 weeks finished lower.
Best week+4.9%Week of 17 Apr.
Worst week-6.3%Week of 26 Jun.
Latest week+0.9%Week of 31 Jul.
Shape of recent returns
Strong gains1
Modest gains12
Flat weeks1
Modest losses7
Sharp losses5
Recent vol3.0%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Financial Services
4-week rank67 / 95
Group average0.1%
Trend breadth58.9%
Trend58.9%active weekly trend signals
MD67.4%positive activity pressure
RS49.5%positive relative leadership
Four-week leaders
IndustryDE Credit Services
4-week rank3 / 7
Group average-2.6%
Trend breadth28.6%
Trend28.6%active weekly trend signals
MD85.7%positive activity pressure
RS28.6%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape22/100
Trend, activity pressure, participation, and risk combine to a 22/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.
Activity pressure 0.06; No reversal markers Factors22/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 65; Small Cap Core rank 30 SVQF15/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 314.5 of 372 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment57/100Weighted news tone is neutral across 3 relevant articles.
Why The Grenke (XTRA:GLJ) Story Is Shifting As Analysts Recalibrate Price Targets And Assumptions Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 11.76 EUR | 0.9% | 12.98 EUR | 17.36 EUR | -0.40 | -20.47 | 433.1K | Off |
| 24 Jul 2026 | 11.66 EUR | -3.2% | 13.09 EUR | 17.44 EUR | -0.16 | -20.16 | 280.6K | Off |
| 17 Jul 2026 | 12.04 EUR | 2.2% | 13.19 EUR | 17.52 EUR | 0.00 | -17.44 | 280.5K | Off |
| 10 Jul 2026 | 11.78 EUR | -2.0% | 13.27 EUR | 17.59 EUR | 0.13 | -20.57 | 377.1K | Off |
| 3 Jul 2026 | 12.02 EUR | 1.9% | 13.36 EUR | 17.67 EUR | 0.22 | -21.77 | 834.2K | Off |
| 26 Jun 2026 | 11.80 EUR | -6.3% | 13.44 EUR | 17.76 EUR | 0.04 | -20.31 | 67.8K | Off |
| 19 Jun 2026 | 12.60 EUR | 1.0% | 13.56 EUR | 17.85 EUR | 0.11 | -16.40 | 38.4K | Off |
| 12 Jun 2026 | 12.48 EUR | 0.6% | 13.59 EUR | 17.92 EUR | -0.03 | -16.21 | 98.2K | Off |
| 5 Jun 2026 | 12.40 EUR | -4.6% | 13.63 EUR | 18.01 EUR | -0.04 | -17.32 | 64.8K | Off |
| 29 May 2026 | 13.00 EUR | 3.0% | 13.68 EUR | 18.09 EUR | -0.11 | -14.70 | 386.7K | Off |
| 22 May 2026 | 12.62 EUR | 0.0% | 13.73 EUR | 18.18 EUR | -0.31 | -16.59 | 374.3K | Off |
| 15 May 2026 | 12.62 EUR | 3.3% | 13.83 EUR | 18.27 EUR | -0.37 | -13.39 | 848.6K | Off |
| 8 May 2026 | 12.22 EUR | -3.9% | 13.91 EUR | 18.36 EUR | -0.50 | -17.59 | 614.3K | Off |
| 1 May 2026 | 12.72 EUR | -0.8% | 14.03 EUR | 18.45 EUR | -0.56 | -14.28 | 350.3K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.